Post your clinical trial on JoinClinicalTrials.com to reach thousands of viewer daily. Our Clinical Trial Listings have consistently proven to be an ...
Condition: Effects of Immulina on Natural Killer Cells Intervention: Dietary Supplement: Immulina Dietary Supplementation Sponsor: University of Mississippi Medical Center Recruiting
Condition: Cervical Cancer Interventions: Behavioral: Pap testing; Behavioral: Choice Sponsors: University of Alabama at Birmingham; American Cancer Society, Inc. Recruiting
Conditions: Concussion, Mild; Sport Injury Intervention: Other: Virtual Reality Sensorimotor Training Sponsors: University of Mississippi Medical Center; University of West Alabama; Mississippi College Enrolling by invitation
Condition: HIV/AIDS Intervention: Behavioral: Tele-PrEP Intervention Sponsors: Rhode Island Hospital; University of Mississippi Medical Center Not yet recruiting
Condition: Spinal Cord Injuries Interventions: Combination Product: HIIT-FES Cycling combined with Nutritional Counseling; Other: Nutritional Counseling Only Sponsors: William Carey University; University of Southern Mississippi; University of Mississippi Medical Center Completed
Condition: Diabetes Interventions: Behavioral: Home Visitiation; Behavioral: Education Sponsors: Delta Health Alliance; University of Tennessee Health Science Center Active, not recruiting
Conditions: Lung Cancer; Smoking Cessation; Tobacco Use Cessation Interventions: Behavioral: Patient Decision Aid; Behavioral: Standard Educational Information; Behavioral: Follow-Up Assessments: Questionnaires Sponsors: M.D. Anderson Cancer Center; Patient-Centered Outcomes Research Institute Active, not recruiting
Conditions: Hiv; Adolescent Behavior; Family Relations; Sexual Orientation Interventions: Behavioral: MySTYLE; Other: Waitlist Control Sponsors: Rhode Island Hospital; University of Mississippi Medical Center Enrolling by invitation
Conditions: Seemingly Healthy; Genetic Predisposition to Disease Intervention: Genetic: Genomic Sequencing Sponsors: Brigham and Women's Hospital; Framingham Heart Study; Jackson Heart Study; Broad Institute; University of Mississippi Medical Center; Boston University; Partners HealthCare Not yet recruiting
Condition: HIV Infections Interventions: Behavioral: HealthMindr App; Behavioral: Control App Sponsors: Emory University; National Institutes of Health (NIH); National Institute on Drug Abuse (NIDA) Not yet recruiting
Condition: Hepatitis C Intervention: Other: HCV Screening Sponsors: Denver Health and Hospital Authority; Johns Hopkins University; University of Mississippi Medical Center; Boston University; Boston Medical Center; University of Cincinnati; Alameda County Medical Center Not yet recruiting
Conditions: Medication Adherence; HIV/AIDS Interventions: Behavioral: Multilevel Gaming Adherence Intervention; Behavioral: Treatment as Usual + Sponsors: Rhode Island Hospital; University of Mississippi Medical Center; Boston Medical Center Enrolling by invitation
Conditions: Acute Coronary Syndrome; Chest Pain Interventions: Procedure: Cardiac MRI; Other: ACC/AHA Guideline adherent care Sponsors: Wake Forest University Health Sciences; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI) Active, not recruiting
Condition: Atrial Fibrillation Intervention: Behavioral: Decision Aid Sponsors: Mayo Clinic; Park Nicollet Clinic; Hennepin County Medical Center, Minneapolis; National Heart, Lung, and Blood Institute (NHLBI) Enrolling by invitation
Condition: Previously Treated Non-Small Cell Lung Cancer Intervention: Drug: Screening Platform Sponsors: Southwest Oncology Group; National Cancer Institute (NCI) Recruiting
Conditions: Cardiotoxicity; HER2/Neu Positive; Metastatic Malignant Neoplasm in the Brain; Recurrent Breast Carcinoma; Stage IV Breast Cancer AJCC v6 and v7 Interventions: Drug: Carvedilol; Other: Laboratory Biomarker Analysis; Other: Patient Observation Sponsors: Southwest Oncology Group; National Cancer Institute (NCI) Recruiting
Conditions: Anatomic Stage IV Breast Cancer AJCC v8; Estrogen Receptor Positive; HER2/Neu Negative; Progesterone Receptor Positive; Prognostic Stage IV Breast Cancer AJCC v8; Elevated CA15-3 or CEA or CA27-29 Interventions: Other: Usual care disease monitoring; Other: Serum Tumor Marker directed disease monitoring; Other: Quality-of-Life Assessment; Other: Anxiety Questionnaire Administration Sponsors: Southwest Oncology Group; National Cancer Institute (NCI) Recruiting
Condition: Multiple Sclerosis Interventions: Behavioral: DirectCAM; Behavioral: TeleCAM Sponsors: University of Alabama at Birmingham; Patient-Centered Outcomes Research Institute; Lakeshore Foundation; Tanner Foundation for Neurological Diseases Recruiting
Condition: Node Positive HER2 Negative Breast Cancer Interventions: Other: Placebo; Drug: Aspirin Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); United States Department of Defense; Bayer; Canadian Cancer Trials Group Recruiting
Condition: Breast Carcinoma Interventions: Other: Health Education Program; Other: Weight Loss Intervention Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); Division of Cancer Control; NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP); Canadian Cancer Trials Group Recruiting
Conditions: Breast Carcinoma Metastatic in the Brain; Recurrent Breast Carcinoma; Stage IV Breast Cancer AJCC v6 and v7; Triple-Negative Breast Carcinoma Interventions: Drug: Cisplatin; Other: Laboratory Biomarker Analysis; Other: Placebo Administration; Drug: Veliparib Sponsor: National Cancer Institute (NCI) Active, not recruiting
Conditions: Invasive Breast Carcinoma; Stage 0 Breast Cancer AJCC v6 and v7; Stage I Breast Cancer AJCC v7; Stage IA Breast Cancer AJCC v7; Stage IB Breast Cancer AJCC v7; Stage II Breast Cancer AJCC v6 and v7; Stage IIA Breast Cancer AJCC v6 and v7; Stage IIB Breast Cancer AJCC v6 and v7; Stage III Breast Cancer AJCC v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIB Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7; Triple-Negative Breast Carcinoma Interventions: Other: Laboratory Biomarker Analysis; Other: Patient Observation; Biological: Pembrolizumab; Other: Quality-of-Life Assessment; Other: Questionnaire Administration; Radiation: Radiation Therapy Sponsor: National Cancer Institute (NCI) Recruiting
Condition: Lung Carcinoma Interventions: Drug: Varenicline; Drug: Placebo; Other: Tobacco Cessation Counseling Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); Pfizer Active, not recruiting
Conditions: Breast Adenocarcinoma; HER2/Neu Negative; Locally Advanced Breast Carcinoma; Metastatic Breast Carcinoma; Recurrent Breast Carcinoma; Stage III Breast Cancer AJCC v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIB Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7; Stage IV Breast Cancer AJCC v6 and v7 Interventions: Drug: Entinostat; Drug: Exemestane; Drug: Goserelin; Drug: Goserelin Acetate; Other: Placebo Administration; Other: Quality-of-Life Assessment Sponsor: National Cancer Institute (NCI) Active, not recruiting
Conditions: Stage II Breast Cancer; Stage IIIA Breast Cancer Interventions: Procedure: Axillary Lymph Node Dissection (ALND); Radiation: Nodal Radiation Therapy; Radiation: Axillary Radiation Therapy Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); Canadian Cancer Trials Group Suspended
Conditions: Estrogen Receptor-positive Breast Cancer; HER2-negative Breast Cancer; Invasive Ductal Breast Carcinoma; Invasive Lobular Breast Carcinoma; Recurrent Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer Interventions: Drug: fulvestrant; Drug: anastrozole Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI) Active, not recruiting
Conditions: Cognitive Dysfunction; Memory Impairment Interventions: Drug: Donepezil 5 mg; Drug: Placebo Sponsors: Wake Forest University Health Sciences; National Cancer Institute (NCI) Recruiting
Conditions: Ductal Breast Carcinoma In Situ; Invasive Breast Carcinoma; Multicentric Breast Carcinoma; Multifocal Breast Carcinoma; Synchronous Bilateral Breast Carcinoma Interventions: Drug: Anastrozole; Drug: Exemestane; Other: Laboratory Biomarker Analysis; Drug: Letrozole; Other: Quality-of-Life Assessment; Drug: Systemic Chemotherapy; Drug: Tamoxifen Citrate Sponsor: National Cancer Institute (NCI) Active, not recruiting
Condition: Lung Cancer Interventions: Radiation: Standard Radiation Dose Therapy; Drug: cisplatin; Drug: etoposide; Radiation: High Radiation Dose Therapy; Drug: carboplatin Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI) Recruiting
Condition: Osteoarthritis Interventions: Drug: Celecoxib; Drug: Any commercially available NSAID with the indication for osteoarthritis Sponsor: Pfizer Completed
Condition: Colorectal Cancer Interventions: Biological: cetuximab; Drug: irinotecan hydrochloride; Drug: vemurafenib Sponsors: Southwest Oncology Group; National Cancer Institute (NCI); Roche-Genentech Active, not recruiting
Condition: Ductal Breast Carcinoma In Situ Interventions: Other: Laboratory Biomarker Analysis; Biological: Trastuzumab; Radiation: Whole Breast Irradiation Sponsors: National Cancer Institute (NCI); NRG Oncology Active, not recruiting
Conditions: Breast Adenocarcinoma; Estrogen Receptor and/or Progesterone Receptor Positive; Stage IA Breast Cancer AJCC v7; Stage IB Breast Cancer AJCC v7; Stage IIA Breast Cancer AJCC v6 and v7; Stage IIB Breast Cancer AJCC v6 and v7; Stage IIIB Breast Cancer AJCC v7 Interventions: Drug: Anastrozole; Drug: Exemestane; Other: Laboratory Biomarker Analysis; Drug: Letrozole; Other: Quality-of-Life Assessment; Radiation: Radiation Therapy; Drug: Tamoxifen Citrate Sponsors: National Cancer Institute (NCI); American College of Surgeons; Cancer and Leukemia Group B; NSABP Foundation Inc; NCIC Clinical Trials Group; North Central Cancer Treatment Group; Southwest Oncology Group Active, not recruiting
Conditions: Extensive Stage Lung Small Cell Carcinoma; Recurrent Lung Small Cell Carcinoma Interventions: Drug: Carboplatin; Drug: Cisplatin; Drug: Etoposide; Biological: Nivolumab Sponsor: National Cancer Institute (NCI) Active, not recruiting
Condition: Breast Cancer Interventions: Drug: cyclophosphamide; Drug: docetaxel; Drug: doxorubicin hydrochloride Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI); Southwest Oncology Group; North Central Cancer Treatment Group; Cancer and Leukemia Group B Completed
Condition: Neoplasms, Breast Interventions: Drug: Lapatinib; Biological: Trastuzumab Sponsors: Novartis Pharmaceuticals; North Central Cancer Treatment Group; National Cancer Institute (NCI); Breast International Group; Canadian Cancer Trials Group Active, not recruiting
Condition: Inflammatory Breast Carcinoma Interventions: Drug: Olaparib; Radiation: Radiation Therapy Sponsor: National Cancer Institute (NCI) Recruiting
Condition: Breast Cancer Interventions: Drug: Tesetaxel and Capecitabine; Drug: Capecitabine Sponsor: Odonate Therapeutics, Inc. Active, not recruiting
Conditions: Arthropathy of Knee; Antibiotic Prophylaxis Intervention: Drug: Cefazolin Sponsors: Duke University; American Association of Hip and Knee Society Recruiting
Conditions: Coronary Artery Disease; Ischemic Heart Disease; Non ST Segment Elevation Myocardial Infarction Interventions: Device: Orbital Atherectomy; Device: Balloon Sponsors: Cardiovascular Systems Inc; Cardiovascular Research Foundation, New York Recruiting
Conditions: Metastatic Malignant Neoplasm in Lymph Node; Metastatic Malignant Neoplasm in the Adrenal Gland; Metastatic Malignant Neoplasm in the Lung; Metastatic Malignant Neoplasm in the Pancreas; Metastatic Malignant Neoplasm in the Skin; Metastatic Malignant Neoplasm in the Soft Tissues; Metastatic Renal Cell Carcinoma; Sarcomatoid Renal Cell Carcinoma; Stage II Renal Cell Cancer AJCC v7; Stage III Renal Cell Cancer AJCC v7; Unclassified Renal Cell Carcinoma Interventions: Procedure: Conventional Surgery; Biological: Nivolumab; Other: Patient Observation; Other: Quality-of-Life Assessment; Other: Questionnaire Administration Sponsors: National Cancer Institute (NCI); Canadian Cancer Trials Group Recruiting
Condition: Migraine, With or Without Aura Interventions: Drug: Ubrogepant; Drug: Placebo-matching Ubrogepant; Drug: Usual Care Sponsor: Allergan Completed
Conditions: Recurrent Breast Carcinoma; Stage III Breast Cancer AJCC v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIB Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7; Stage IV Breast Cancer AJCC v6 and v7 Interventions: Other: Laboratory Biomarker Analysis; Other: Pharmacological Study; Drug: Tamoxifen Citrate; Drug: Z-Endoxifen Hydrochloride Sponsor: National Cancer Institute (NCI) Active, not recruiting
Condition: Crohn's Disease Interventions: Drug: Rifaximin EIR; Drug: Placebo Sponsors: Bausch Health Americas, Inc.; Salix Pharmaceuticals, Inc. a division of Bausch Health US, LLC Terminated
Conditions: Heart Failure; Tachycardia, Ventricular Intervention: Device: St. Jude Medical Optisure Lead Sponsor: Abbott Medical Devices Active, not recruiting
Condition: Moderate to Very Severe Chronic Obstructive Pulmonary Disease Interventions: Drug: Benralizumab Arm A; Drug: Benralizumab Arm B; Drug: Benralizumab Arm C; Drug: Placebo Sponsors: AstraZeneca; MedImmune LLC Completed
Condition: Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD) Interventions: Drug: Epanova® (omega-3 carboxylic acids); Drug: corn oil control Sponsors: AstraZeneca; The Cleveland Clinic; IQVIA RDS Inc. Active, not recruiting
Conditions: Stage IB Breast Cancer; Stage II Breast Cancer Interventions: Radiation: regional nodal XRT; Radiation: chestwall XRT; Radiation: WBI Sponsors: NSABP Foundation Inc; National Cancer Institute (NCI); Radiation Therapy Oncology Group Recruiting
Conditions: HER2 Positive Breast Carcinoma; Invasive Breast Carcinoma; Metastatic Malignant Neoplasm in the Brain; Recurrent Breast Carcinoma; Stage IV Breast Cancer AJCC v6 and v7 Interventions: Other: Laboratory Biomarker Analysis; Drug: Lapatinib Ditosylate; Radiation: Stereotactic Radiosurgery; Radiation: Whole-Brain Radiotherapy Sponsors: National Cancer Institute (NCI); NRG Oncology Active, not recruiting
Condition: Prostate Cancer Interventions: Radiation: radiation therapy; Radiation: Whole-pelvic radiotherapy (WPRT) Sponsors: Radiation Therapy Oncology Group; National Cancer Institute (NCI); NRG Oncology Active, not recruiting
Conditions: Adenocarcinoma of the Gastroesophageal Junction; Esophageal Cancer Interventions: Drug: Oxaliplatin; Drug: Leucovorin Calcium; Drug: Fluorouracil; Drug: Carboplatin; Drug: Paclitaxel; Procedure: Positron Emission Tomography; Procedure: Computed Tomography; Radiation: Radiation Therapy Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI) Active, not recruiting
Conditions: Anemia; Chronic Myelomonocytic Leukemia; de Novo Myelodysplastic Syndrome; Myelodysplastic Syndrome Interventions: Biological: Epoetin Alfa; Other: Laboratory Biomarker Analysis; Drug: Lenalidomide Sponsor: National Cancer Institute (NCI) Active, not recruiting
Conditions: Invasive Breast Carcinoma; Recurrent Breast Carcinoma; Stage III Breast Cancer AJCC v6; Stage IV Breast Cancer AJCC v6 and v7 Interventions: Biological: Bevacizumab; Other: Laboratory Biomarker Analysis; Drug: Letrozole; Other: Questionnaire Administration; Drug: Tamoxifen Citrate Sponsor: National Cancer Institute (NCI) Active, not recruiting
Conditions: Lung Cancer; Radiation Toxicity Interventions: Biological: Cetuximab; Drug: Carboplatin; Drug: Paclitaxel; Radiation: 60 Gy RT; Radiation: 74 Gy RT Sponsors: Radiation Therapy Oncology Group; National Cancer Institute (NCI); North Central Cancer Treatment Group; Cancer and Leukemia Group B; NRG Oncology Active, not recruiting
Conditions: Estrogen Receptor Positive; HER2 Positive Breast Carcinoma; HER2/Neu Negative; Progesterone Receptor Positive; Recurrent Breast Carcinoma; Stage IIIB Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7; Stage IV Breast Cancer AJCC v6 and v7 Interventions: Drug: Fulvestrant; Other: Laboratory Biomarker Analysis; Drug: Lapatinib Ditosylate; Other: Placebo Sponsor: National Cancer Institute (NCI) Active, not recruiting
Condition: Metastatic Hormone-sensitive Prostate Cancer Interventions: Drug: androgen-deprivation therapy; Drug: docetaxel Sponsors: ECOG-ACRIN Cancer Research Group; National Cancer Institute (NCI) Active, not recruiting
Condition: Breast Cancer Interventions: Biological: pegfilgrastim; Drug: AC regimen; Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: paclitaxel Sponsors: Southwest Oncology Group; National Cancer Institute (NCI) Active, not recruiting
Conditions: Diabetes; Pregnancy Interventions: Drug: Metformin; Drug: Placebo Sponsors: University of North Carolina, Chapel Hill; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting
Condition: Traumatic Amputation of Lower Extremity Intervention: Sponsors: Major Extremity Trauma Research Consortium; University of California, San Francisco Active, not recruiting